Target intelligence / Profile preview

GRPEL2 antisense RNA 1 (GRPEL2-AS1)

Target
GRPEL2-AS1
Molecular classification
Long noncoding RNA (lncRNA)
01

Overview

GRPEL2 antisense RNA 1 is a noncoding RNA gene annotated in public resources such as GeneCards and Ensembl, distinguished primarily by its transcription from the antisense strand of the GRPEL2 gene locus[1]. It belongs to the lncRNA functional class, but as of this writing, no established biological function, disease association, or therapeutic relevance is available in curated gene/protein databases or the scientific literature. The gene is referenced in databases under external identifiers such as HGNC:48999, NCBI Gene:106144529, and Ensembl:ENSG00000253618[1]. No phenotype, biomarker, or drug–target relationships are documented for GRPEL2-AS1. There is no apparent error or misspelling in the target name itself, but information is sparse, and no evidence indicates that GRPEL2-AS1 is a protein-coding gene, biological receptor, or enzyme. It should not be confused with GRPEL2 (the protein-coding gene for a mitochondrial nucleotide-exchange factor)[3], which is unrelated functionally and structurally. This lncRNA is thus best classified in molecular inventories as: - A long noncoding RNA (lncRNA) antisense to GRPEL2 - Not a classical drug target, receptor, enzyme, transporter, transcription factor, or signaling regulator within current bioinformatics and clinical annotation standards[1]

Other names
RP11-394O4.4GRPEL2-AS1
02

Biological functions

Other (no experimentally established function for this lncRNA; likely regulatory, but mechanism and specific pathway involvement have not been characterized in peer-reviewed literature or major databases[1])
03

Disease associations

Other (no described disease association in current curated resources or literature[1])

Beyond the preview

Go deeper on GRPEL2 antisense RNA 1 (GRPEL2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GRPEL2 antisense RNA 1 (GRPEL2-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call